NEUROPHYSIOLOGY OF STRIATAL NEURONS AFTER ISCHEMIA
Project Number1R01NS038053-01
Former Number1R01NS036148-01A1
Contact PI/Project LeaderXU, ZAO C
Awardee OrganizationINDIANA UNIVERSITY INDIANAPOLIS
Description
Abstract Text
DESCRIPTION: (Applicant's abstract) Cerebrovascular disease (stroke) is
the third leading cause of death, and the number one cause of disability
in the United States. The applicant's long-term goal is to identify
mechanisms of neuronal damage following transient cerebral ischemia CA1
neurons in hippocampus and spiny neurons in neostriatum are highly
vulnerable to transient forebrain ischemia. The current knowledge about
the pathogenesis of post-ischemic neuronal injury is mainly derived from
studies on hippocampal neurons. Little is known about the
neurophysiological changes in striatal about the neurophysiological
changes of striatal neurons following ischemia. The temporal threshold for
injury and the time course of cell loss differ dramatically between
hippocampus and neostriatum. The mechanisms underlying the neuronal injury
in these two regions may not be the same. Studies have shown that the
synaptic transmission of CA1 neurons enhances after lethal ischemia. It
has also been shown that depletion of dopamine neurons dramatically
reduces the post-ischemic neuronal damage in neostriatum. The working
hypothesis of this proposal is that dopamine neurons dramatically reduces
the post-ischemic neuronal damage in neostriatum. The working hypothesis
of this proposal is that dopamine aggravates the post-ischemic neuronal
injury by potentiating glutamate excitoxicity. The experiments in this
proposal are designed to determine: 1) Whether the synaptic transmission
of spiny neurons if facilitated after ischemia and thereby cause neuronal
injury; 2) How dopamine potentiates the synaptic transmission and
aggravates the neuronal damage after ischemia. The specific aims of the
proposed experiments are:
To compare the synaptic transmission of spiny neurons in neostriatum
before and after 22 min forebrain ischemia. 2. To study the synaptic
transmission of interneurons in neostriatum before and after 22 min
ischemia and compare with that of spiny neurons. 3. To analyze the post-
ischemic neurophysiological changes of spiny neurons after dopamine
depletion and compare with those in intact neostriatum. 4. To determine
the mechanisms of asymmetrical protection of striatal neurons against
ischemia after dopamine depletion. The results of the proposed experiments
will identify the electrophysiological changes correlated with the
selective neuronal injury in neostriatum following forebrain ischemia and
improve our understanding of the mechanism of brain damage upon
resuscitation following cardiac arrest.
National Institute of Neurological Disorders and Stroke
CFDA Code
DUNS Number
603007902
UEI
SHHBRBAPSM35
DKNHLK3NBPH7
DL9MTNNKWYR9
GY8GKRUWM7D5
HA48EWMJFV47
HCNBFNDANNV5
HCRDU7BNPZ13
HCWTYJ7KQ4U6
HEBLAL94JHP7
NKCRSKVJBXE3
TA1NYNZ27LQ7
WJJRCLJ936C8
X51WYC1QEPD7
XNBJV454V2W1
YCJNP5NJYCY1
YW8WNKKANDR9
625168166
N/A
Project Start Date
01-April-1998
Project End Date
28-February-2002
Budget Start Date
01-April-1998
Budget End Date
28-February-1999
Project Funding Information for 1998
Total Funding
$194,518
Direct Costs
$148,967
Indirect Costs
$45,551
Year
Funding IC
FY Total Cost by IC
1998
National Institute of Neurological Disorders and Stroke
$194,518
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 1R01NS038053-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R01NS038053-01
Patents
No Patents information available for 1R01NS038053-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R01NS038053-01
Clinical Studies
No Clinical Studies information available for 1R01NS038053-01
News and More
Related News Releases
No news release information available for 1R01NS038053-01
History
No Historical information available for 1R01NS038053-01
Similar Projects
No Similar Projects information available for 1R01NS038053-01